Liyan Xu

发表

[Acceptable safety of bevacizumab therapy in combination with chemotherapy in patients with advanced lung cancer.].

Mingzhi Li, H. Tao, Zan Liu, 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Multicenter, randomized study of genetically modified recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy

Yang Zhang, Sunyoung Kim, Y. Teng, 2012, Supportive Care in Cancer.

[Long-term survival of a patient with advanced non-small cell lung cancer on bevacizumab therapy: case report and review of the literature].

Mingzhi Li, H. Tao, Zan Liu, 2013, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Clinical Observation of Erlotinib in the Treatment of Advanced and Previously Treated Non-small Cell Lung Cancer.].

Wei Wu, Mingzhi Li, Zan Liu, 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[The relationship between EGFR mutations and response and prognosis of tyrosine kinase inhibitors in advanced Non-small-cell Lung Cancer.].

Wei Wu, Hui Wang, Chunyan Zhang, 2008, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

凡德他尼治疗5例晚期复治肺腺癌患者的临床观察及相关文献回顾

Zhe Liu, Junfang Tang, Lili Guo, 2012, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[Adverse events of afatinib as first-line treatment for five cases of advanced lung adenocarcinoma and review of literature].

Wei Wu, Mingzhi Li, H. Tao, 2014, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Phase III clinical trials of the cell differentiation agent-2 (CDA-2): Therapeutic efficacy on breast cancer, non-small cell lung cancer and primary hepatoma1

C. Ling, Qiang Chen, Z. Meng, 2005 .

Should we excise? Are there any clinical or histologic features that predict upgrade in papillomas, incidental or non-incidental?

D. Karamchandani, A. Chetlen, J. Mack, 2018, Annals of diagnostic pathology.

Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma—A Retrospective Analysis of a Multicenter Clinical Study

Hanxiao Chen, M. Zhuo, Jun Zhao, 2021, Frontiers in Molecular Biosciences.

A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer

Baolan Li, Wei Li, Chengping Hu, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases

Wei Wu, H. Tao, Hongxia Li, 2021, Frontiers in Oncology.

[A Retrospective Study of Erlotinib in the Treatment of 70 Patients with Non-small Cell Lung Cancer.].

Wei Wu, Mingzhi Li, H. Tao, 2009, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

D. Karamchandani, A. Chetlen, J. Mack, 2019, The breast journal.